Literature DB >> 17702861

Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation.

Xuguang Tai1, Francois Van Laethem, Arlene H Sharpe, Alfred Singer.   

Abstract

CTLA-4-deficient mice develop a lethal autoimmune lymphoproliferative disorder that is strictly dependent on in vivo CD28 costimulation. Nevertheless, it is not known whether there is a specific site on the CD28 molecule that is required for induction of autoimmunity. Using CTLA-4-deficient mice expressing CD28 molecules with various point mutations in the CD28 cytosolic tail, the present study documents that in vivo costimulation for induction of autoimmune disease strictly requires an intact C-terminal proline motif that promotes lymphocyte-specific protein tyrosine kinase Lck binding to the CD28 cytosolic tail, because point mutations in C-terminal proline residues (Pro-187 and Pro-190) completely prevented disease induction. In contrast, in vivo costimulation for disease induction did not require either an intact YMNM motif or an intact N-terminal proline motif, which, respectively, promote phosphoinositide 3-kinase and IL2-inducible T cell kinase binding to the CD28 cytosolic tail. Thus, in vivo CD28 costimulation for induction of autoimmune disease is strictly and specifically dependent on an intact C-terminal proline motif that serves as a lymphocyte-specific protein tyrosine Lck kinase binding site in the CD28 cytosolic tail.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702861      PMCID: PMC1949493          DOI: 10.1073/pnas.0706509104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Thymocyte development is normal in CTLA-4-deficient mice.

Authors:  C A Chambers; D Cado; T Truong; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association.

Authors:  F Pagès; M Ragueneau; S Klasen; M Battifora; D Couez; R Sweet; A Truneh; S G Ward; D Olive
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

3.  Requirement for p56lck tyrosine kinase activation in T cell receptor-mediated thymic selection.

Authors:  K Hashimoto; S J Sohn; S D Levin; T Tada; R M Perlmutter; T Nakayama
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

4.  Differential T cell costimulatory requirements in CD28-deficient mice.

Authors:  A Shahinian; K Pfeffer; K P Lee; T M Kündig; K Kishihara; A Wakeham; K Kawai; P S Ohashi; C B Thompson; T W Mak
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

5.  Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling.

Authors:  F Pagès; M Ragueneau; R Rottapel; A Truneh; J Nunes; J Imbert; D Olive
Journal:  Nature       Date:  1994-05-26       Impact factor: 49.962

6.  Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation.

Authors:  Pietro G Andres; Kimberly C Howland; Ajay Nirula; Lawrence P Kane; Luke Barron; Douglas Dresnek; Ali Sadra; John Imboden; Arthur Weiss; Abul K Abbas
Journal:  Nat Immunol       Date:  2004-03-07       Impact factor: 25.606

7.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

8.  T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras.

Authors:  H Schneider; Y C Cai; K V Prasad; S E Shoelson; C E Rudd
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

9.  p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation.

Authors:  M Raab; Y C Cai; S C Bunnell; S D Heyeck; L J Berg; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

10.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

View more
  37 in total

Review 1.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

2.  Activated T cells secrete an alternatively spliced form of common γ-chain that inhibits cytokine signaling and exacerbates inflammation.

Authors:  Changwan Hong; Megan A Luckey; Davinna L Ligons; Adam T Waickman; Joo-Young Park; Grace Y Kim; Hilary R Keller; Ruth Etzensperger; Xuguang Tai; Vanja Lazarevic; Lionel Feigenbaum; Marta Catalfamo; Scott T R Walsh; Jung-Hyun Park
Journal:  Immunity       Date:  2014-06-05       Impact factor: 31.745

3.  Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  Arthritis Rheumatol       Date:  2018-01-30       Impact factor: 10.995

4.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.

Authors:  Lucy S K Walker; David M Sansom
Journal:  Nat Rev Immunol       Date:  2011-11-25       Impact factor: 53.106

Review 5.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy.

Authors:  Dipankar Nandi; Sanmoy Pathak; Taru Verma; Madhulika Singh; Avik Chattopadhyay; Samriddhi Thakur; Abinaya Raghavan; Abhijeet Gokhroo
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

6.  CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors.

Authors:  Chan-Wang J Lio; Lindzy F Dodson; Christine M Deppong; Chyi-Song Hsieh; Jonathan M Green
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

Review 7.  At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy.

Authors:  Andrew M Intlekofer; Craig B Thompson
Journal:  J Leukoc Biol       Date:  2013-04-26       Impact factor: 4.962

8.  The living eye "disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition.

Authors:  Ru Zhou; Reiko Horai; Phyllis B Silver; Mary J Mattapallil; Carlos R Zárate-Bladés; Wai Po Chong; Jun Chen; Rachael C Rigden; Rafael Villasmil; Rachel R Caspi
Journal:  J Immunol       Date:  2012-01-11       Impact factor: 5.422

Review 9.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.

Authors:  Jessica Dobbins; Etienne Gagnon; Jernej Godec; Jason Pyrdol; Dario A A Vignali; Arlene H Sharpe; Kai W Wucherpfennig
Journal:  Sci Signal       Date:  2016-07-26       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.